| |
| |
|
| Insider
Information: |
Klein Matthew B. |
| Relationship: |
Director |
| City: |
South Plainfield |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
238,079 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,659,373 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
238,079 |
|
|
| Total
Value |
$7,659,373 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PTC Therapeutics, Inc. |
PTCT |
|
2024-04-19 |
225,807 |
2020-04-16 |
0 |
Premium* |
|
|
ClearPoint Neuro, Inc |
CLPT |
Director |
2022-05-25 |
12,272 |
2021-06-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-04-19 |
4 |
S |
$24.89 |
$83,669 |
D/D |
(3,361) |
225,807 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-04-17 |
4 |
S |
$25.14 |
$32,851 |
D/D |
(1,307) |
229,168 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
230,475 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-01-09 |
4 |
S |
$29.01 |
$157,928 |
D/D |
(5,443) |
160,475 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-01-08 |
4 |
S |
$28.64 |
$64,068 |
D/D |
(2,237) |
165,918 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-01-05 |
4 |
S |
$27.15 |
$274,393 |
D/D |
(10,107) |
168,155 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-12-28 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
177,961 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• – – |
2023-04-18 |
4 |
A |
$0.00 |
$0 |
D/D |
26,000 |
103,856 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• – – |
2023-04-18 |
4 |
S |
$52.04 |
$63,025 |
D/D |
(1,211) |
102,645 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF OPERATING OFFICER |
• – – |
2023-01-11 |
4 |
S |
$44.36 |
$99,543 |
D/D |
(2,244) |
77,856 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF OPERATING OFFICER |
• – – |
2023-01-10 |
4 |
S |
$42.93 |
$97,586 |
D/D |
(2,273) |
80,100 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF OPERATING OFFICER |
• – – |
2023-01-09 |
4 |
S |
$41.66 |
$30,451 |
D/D |
(731) |
82,373 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF OPERATING OFFICER |
• – – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
26,000 |
83,104 |
0 |
- |
|
| CLPT |
ClearPoint Neuro, Inc |
Director |
– • – |
2022-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,269 |
12,272 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF OPERATING OFFICER |
• – – |
2022-04-19 |
4 |
S |
$42.52 |
$38,136 |
D/D |
(897) |
56,564 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
41,000 |
57,461 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-01-07 |
4 |
S |
$38.53 |
$29,857 |
D/D |
(775) |
16,461 |
0 |
% |
|
| CLPT |
ClearPoint Neuro, Inc |
Director |
– • – |
2021-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,003 |
3,003 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Development Officer |
• – – |
2021-04-20 |
4 |
AS |
$46.58 |
$76,704 |
D/D |
(1,641) |
16,809 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Development Officer |
• – – |
2021-04-19 |
4 |
AS |
$48.17 |
$41,376 |
D/D |
(859) |
18,450 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Development Officer |
• – – |
2021-01-15 |
4 |
OE |
$38.98 |
$167,614 |
D/D |
4,300 |
23,609 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Development Officer |
• – – |
2021-01-15 |
4 |
AS |
$69.09 |
$297,078 |
D/D |
(4,300) |
19,309 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Development Officer |
• – – |
2021-01-08 |
4 |
AS |
$69.48 |
$383,410 |
D/D |
(5,500) |
19,309 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Development Officer |
• – – |
2021-01-08 |
4 |
OE |
$38.98 |
$214,390 |
D/D |
5,500 |
24,809 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Development Officer |
• – – |
2021-01-07 |
4 |
AS |
$68.98 |
$268,056 |
D/D |
(3,886) |
19,309 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
